The Economic Times daily newspaper is available online now.

    Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine

    Synopsis

    The DCGI has asked the company certain conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events during follow-up of the study which has to be "scrupulously" followed by Serum Institute of India (SII).

    4 reuReuters
    India’s drug regulator on Tuesday gave permission to Serum Institute of India (SII) to resume clinical trial of the Oxford Covid-19 vaccine candidate in the country. The drug controller had earlier put on hold the trials after an adverse event was reported in a participant.

    The DCGI on Tuesday revoked its earlier order of suspending any new recruitment for phase two and three trial.
    The permission however comes with a caveat. The DCGI has asked the company certain conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events during follow-up of the study which has to be "scrupulously" followed by Serum Institute of India (SII).

    SII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events.

    The DCGI had on September 11 directed Serum Institute of India to suspend any new recruitment in the phase two and three clinical trial of the Oxford COVID-19 vaccine candidate till further orders after AstraZeneca halted the clinical trials in other countries because of "an unexplained illness" in a participant in the study.

    On Saturday, British-Swedish biopharmaceutical giant AstraZeneca and the University of Oxford said it had resumed the trials for their coronavirus vaccine in the UK after the Medicines Health Regulatory Authority's (MHRA) confirmed that the trials were safe.


    (You can now subscribe to our Economic Times WhatsApp channel)
    (Catch all the Business News, Breaking News, Budget 2024 News, Budget 2024 Live Coverage, Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Subscribe to The Economic Times Prime and read the ET ePaper online.

    ...more

    (You can now subscribe to our Economic Times WhatsApp channel)
    (Catch all the Business News, Breaking News, Budget 2024 News, Budget 2024 Live Coverage, Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Subscribe to The Economic Times Prime and read the ET ePaper online.

    ...more
    The Economic Times

    Stories you might be interested in